2026 Hongyang Wang: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	97	9267	8698	105	100	680	35263

Overview

Hongyang Wang is affiliated with the Second Military Medical University in China. Their research spans multiple fields within biomedical science, with a primary focus on medicine and biochemistry, genetics, and molecular biology. The scientist's work includes extensive studies in molecular biology, cancer research, oncology, surgery, and immunology.

The main topics covered in Hongyang Wang's research include:

Cholangiocarcinoma and Gallbladder Cancer Studies
Cancer Genomics and Diagnostics
MicroRNA in disease regulation
Hepatocellular Carcinoma Treatment and Prognosis
Liver physiology and pathology
Cancer Immunotherapy and Biomarkers
Hearing, Cochlea, Tinnitus, Genetics

The scientist has published in a variety of frequently appearing venues such as:

Cancer Letters
PubMed
Research Square (Research Square)
Frontiers in Immunology
Acta Pharmacologica Sinica

Hongyang Wang has collaborated extensively with several co-authors, including:

Lei Chen (30 joint publications)
Xinyao Qiu (19 joint publications)
Liwei Dong (18 joint publications)
Bo Zheng (18 joint publications)
Siyun Shen (18 joint publications)

Their notable recent papers include:

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas, 2021, published in Cell
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing, 2020, published in Cell Discovery
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis, 2020, published in Nature
Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials, 2020, published in Clinical Cancer Research
Comprehensive analysis of spatial architecture in primary liver cancer, 2021, published in Science Advances

The research output of Hongyang Wang extensively addresses cancer biology and immunology, with particular attention to liver-related pathologies and therapies. They contribute to advancing understanding in cancer diagnostics, treatment avenues like immunotherapy, and cellular mechanisms underlying disease progression. The work also intersects with the study of genetic aspects of hearing-related conditions, illustrating a multidisciplinary approach.

Best Publications

The global burden of liver disease: The major impact of China

Fu‐Sheng Wang;Jian‐Gao Fan;Zheng Zhang;Bin Gao

1534
Citations
EpCAM-positive hepatocellular carcinoma cells are tumor initiating cells with stem/progenitor cell features

Taro Yamashita;Junfang Ji;Anuradha Budhu;Marshonna Forgues

1318
Citations
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA

Le Qu;Jin Ding;Cheng Chen;Zhen-Jie Wu

991
Citations
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.

Tian Fang;Hongwei Lv;Guishuai Lv;Ting Li

925
Citations
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.

Xianwen Ren;Wen Wen;Xiaoying Fan;Wenhong Hou

874
Citations
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

Wen Wen;Wenru Su;Hao Tang;Wenqing Le

721
Citations
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM–positive hepatic cancer stem cells

Junfang Ji;Taro Yamashita;Anuradha Budhu;Marshonna Forgues

644
Citations
New knowledge of the mechanisms of sorafenib resistance in liver cancer.

Yan-jing Zhu;Bo Zheng;Hong-yang Wang;Lei Chen

578
Citations
TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma

Pengyuan Yang;Qi Jing Li;Yuxiong Feng;Yun Zhang

567
Citations
Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells

Wen Yang;He-Xin Yan;Lei Chen;Qiong Liu

500
Citations
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

Qiujin Shen;Jia Fan;Xin-Rong Yang;Yexiong Tan

463
Citations
Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics

Qiang Huang;Yexiong Tan;Peiyuan Yin;Guozhu Ye

456
Citations
A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.

Ping Luo;Peiyuan Yin;Rui Hua;Yexiong Tan

381
Citations
Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents.

Le-Xing Yu;He-Xin Yan;Qiong Liu;Wen Yang

366
Citations
Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.

Emilie A. Bard-Chapeau;Emilie A. Bard-Chapeau;Shuangwei Li;Jin Ding;Sharon S. Zhang

363
Citations
Recurrently deregulated lncRNAs in hepatocellular carcinoma.

Yang Yang;Lei Chen;Jin Gu;Hanshuo Zhang

352
Citations
Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus–Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study

Jianhua Yin;Nan Li;Yifang Han;Jie Xue

350
Citations
Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

Huiping Gao;Kesang Li;Hong Tu;Xiaorong Pan

339
Citations
Precision diagnosis and treatment of liver cancer in China

Jing Fu;Hongyang Wang

305
Citations
Hepatocyte Nuclear Factor 4α Suppresses the Development of Hepatocellular Carcinoma

Bei-Fang Ning;Jin Ding;Chuan Yin;Wei Zhong

289
Citations

Frequent Co-Authors

Meng-Chao Wu Second Military Medical University

Gen-Sheng Feng University of California, San Diego

Michael Q. Zhang The University of Texas at Dallas

Hanfa Zou Chinese Academy of Sciences

Rong Zeng Chinese Academy of Sciences

Mingliang Ye Chinese Academy of Sciences

Wan Yee Lau Chinese University of Hong Kong

Jia Fan Fudan University

Frank J. Gonzalez National Institutes of Health

Mark A. Feitelson Temple University

External Links

Personal website of Hongyang Wang

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in healthcare careers besides traditional medical school, there are numerous flexible online degree options that can open doors to rewarding opportunities. Many students explore affordable online nursing programs, which make a nursing education more accessible and budget-friendly compared to on-campus options.

Current Registered Nurses (RNs) may want to consider advancing their credentials through the cheapest rn to bsn online programs. Earning a BSN can enhance patient care skills and lead to leadership roles. Meanwhile, those who already hold degrees in other fields but wish to become nurses can benefit from direct entry msn programs for non-nursing majors online, allowing a direct transition into advanced nursing practice.

For experienced nurses aiming for careers in academia or research, online phd programs in nursing offer flexible, affordable pathways to the highest level of nursing education. With these online pathways, students can balance career advancement with personal and professional commitments, making it easier to achieve their healthcare goals.